Skip to main content

Topic

Patent Pools

6 published works

  1. Intellectual Property Law Blog

    Synergizing Patents to Drive Innovation and Growth

    By Siraj Husain

    This article originally appeared in The Intellectual Property Strategist. © 2021 ALM Media LLC. Reprinted with permission. Companies have historically turned to patent pools as vehicles for achieving shared objectives. A…

  2. Essential Patent Blog

    DOJ Business Review Letter of University Tech. Licensing Program for Non-SEPs

    By David Long

    The U.S. Department of Justice (DOJ) recently issues a business review letter (BRL) and press release concerning a proposed patent pool of patents owned by universities called the University Technology…

  3. Patents Post-Grant

    Dealing with SEP Demands & Royalty Stacking

    By Scott McKeown, Scott McKeown Wolf Greenfield

    Seeking More Granularity on Patent Pools? Patent pools and groupings of standard essential patents (SEPs) facilitate one-stop shopping of patent licensees. When operated fairly, these arrangements can provide meaningful efficiencies to licensors and…

  4. All About IP

    Standardessentielle Patente, FRAND und Patent-Pools in der Automobilindustrie

    By Konstantin von Werder

    Im Rahmen der Webinarreihe der Automotive-Gruppe von Mayer Brown hat Dr. Ulrich Worm einen Einblick gegeben in das Thema  „Standardessentielle Patente, FRAND und Patent-Pools: Terra Incognita für die Automobilindustrie?“ Sie können…

  5. Essential Patent Blog

    Settlement Update: MPEG LA Patent Pool Litigation Concerning Video Compression Standard Essential Patents

    By Essential Patent Blog

    Back in August, we reported on a series of four patent suits filed in the Southern District of Florida by a group of MPEG LA MPEG-2 patent-pool-licensors targeting television manufacturers Craig Electronics, Curtis International,…

  6. Reproductive Rights Prof Blog

    NIH First Entity to License a Patent on a New AIDS Drug

    By Reproductive Rights

    The New York Times: H.I.V.: National Institutes of Health Licenses Its Patent on a New Drug for AIDS, by Donald G. McNeil: In a move that gave official American backing…